They are not approved by Health Canada and must not be used for human or veterinary consumption, therapeutic application, or self-administration
Results: 15.7% average weight loss (all participants)
Reported benefits (per available research): Studied in animal (rodent) models for tendon, ligament, and muscle healing, with researchers attributing effects to promotion of angiogenesis and fibroblast activity (preclinical studies from a Croatian research group at the University of Zagreb, spanning several decades) Originally investigated for gastroprotective properties
Vondra 2021)
Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation
SS-31 Mitochondrial Anti-Inflammatory Targeting SS-31 (Elamipretide, D-Arg-Dmt-Lys-Phe-NH2) is unique on this list because it targets inflammation at the mitochondrial level